CRISPR Therapeutics CRSP is currently the only company in the world to have secured approval for a CRISPR-based gene therapy developed in partnership with Vertex Pharmaceuticals. Following the landmark...
The Best Stocks to Invest $1,000 in Right Now
Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to bear more fruit.
5 Monster Stocks to Hold for the Next 10 Years
These companies are just starting to realize the potential in up-and-coming fields, like AI and gene editing.
CRSPR Therapeutics has ambitious goals for its gene editing technology and may be getting ready to generate the revenue needed to deliver for shareholders